Jay Olson
Stock Analyst at Oppenheimer
(4.90)
# 271
Out of 4,996 analysts
1180
Total ratings
49.8%
Success rate
26%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Rated: Buy | $100 → $120 | $41.65 | +188.12% | 40 | Sep 22, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $60 → $75 | $37.65 | +99.20% | 8 | Sep 14, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | $32 | $15.75 | +103.17% | 2 | Aug 27, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 → $260 | $190.74 | +36.31% | 26 | Aug 27, 2026 | |
| BIIB Biogen | Rated: Hold | n/a | $227.53 | - | 100 | Aug 17, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $650 | $282.12 | +130.40% | 7 | Aug 17, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $35 | $7.20 | +386.11% | 2 | Aug 14, 2026 | |
| APRE Aprea Therapeutics | Reiterated: Buy | $5 | $0.78 | +541.03% | 2 | Aug 13, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $33 | $10.42 | +216.70% | 8 | Aug 12, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $23.87 | $11.45 | +108.48% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.89 | +533.71% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.26 | +693.65% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $9.56 | +318.41% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $406.09 | +10.81% | 84 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $31.55 | +90.17% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $139.49 | +64.89% | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $120 | $124.64 | -3.72% | 84 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.25 | - | 2 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.80 | - | 15 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $516.34 | - | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.75 | +45.45% | 4 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $2.87 | +213.59% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $20.46 | +95.50% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.32 | +657.58% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $140 | $57.66 | +142.80% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $98.46 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $56.73 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.02 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 → $72 | $40.48 | +77.87% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $182.11 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $36 | $3.60 | +900.00% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.38 | +584.93% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $513.02 | +26.70% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.25 | +381.93% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.57 | +172.37% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $27 | $12.33 | +118.98% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $43.93 | +104.87% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.84 | +334.78% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $2.87 | +527.18% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.5668 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.68 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.73 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $151.37 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $11.94 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $25.43 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $55.76 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.69 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.95 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $10 | $20.44 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.63 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.83 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $3.78 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.04 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.922 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $2.17 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $7 | $13.65 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.77 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.26 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3684 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.54 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.30 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.24 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $0.25 | $3.34 | n/a | 5 | Mar 30, 2016 |
Viking Therapeutics
Sep 22, 2026
Rated: Buy
Price Target: $100 → $120
Current: $41.65
Upside: +188.12%
Definium Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $75
Current: $37.65
Upside: +99.20%
Adlai Nortye Group
Aug 27, 2026
Reiterated: Buy
Price Target: $32
Current: $15.75
Upside: +103.17%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $260
Current: $190.74
Upside: +36.31%
Biogen
Aug 17, 2026
Rated: Hold
Price Target: n/a
Current: $227.53
Upside: -
Praxis Precision Medicines
Aug 17, 2026
Reiterated: Buy
Price Target: $650
Current: $282.12
Upside: +130.40%
Kyntra Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $7.20
Upside: +386.11%
Aprea Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $0.78
Upside: +541.03%
Sagimet Biosciences
Aug 12, 2026
Reiterated: Buy
Price Target: $33
Current: $10.42
Upside: +216.70%
Eupraxia Pharmaceuticals Inc.
Aug 12, 2026
Reiterated: Buy
Price Target: $23.87
Current: $11.45
Upside: +108.48%
Aug 6, 2026
Reiterated: Buy
Price Target: $50
Current: $7.89
Upside: +533.71%
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $1.26
Upside: +693.65%
Aug 6, 2026
Reiterated: Buy
Price Target: $40
Current: $9.56
Upside: +318.41%
Aug 5, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $406.09
Upside: +10.81%
Aug 5, 2026
Reiterated: Buy
Price Target: $60
Current: $31.55
Upside: +90.17%
Jul 31, 2026
Reiterated: Buy
Price Target: $230
Current: $139.49
Upside: +64.89%
Jul 28, 2026
Reiterated: Buy
Price Target: $107 → $120
Current: $124.64
Upside: -3.72%
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.25
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.80
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $516.34
Upside: -
Jul 7, 2026
Reiterated: Buy
Price Target: $20
Current: $13.75
Upside: +45.45%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.87
Upside: +213.59%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $20.46
Upside: +95.50%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
May 8, 2026
Reiterated: Buy
Price Target: $115 → $140
Current: $57.66
Upside: +142.80%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $98.46
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $56.73
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $5.02
Upside: -
Apr 22, 2026
Reiterated: Buy
Price Target: $61 → $72
Current: $40.48
Upside: +77.87%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $182.11
Upside: -
Mar 18, 2026
Reiterated: Buy
Price Target: $44 → $36
Current: $3.60
Upside: +900.00%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $4.38
Upside: +584.93%
Feb 9, 2026
Reiterated: Buy
Price Target: $650
Current: $513.02
Upside: +26.70%
Nov 13, 2025
Reiterated: Buy
Price Target: $6
Current: $1.25
Upside: +381.93%
Nov 13, 2025
Reiterated: Buy
Price Target: $7
Current: $2.57
Upside: +172.37%
Nov 7, 2025
Reiterated: Buy
Price Target: $40 → $27
Current: $12.33
Upside: +118.98%
Oct 27, 2025
Reiterated: Buy
Price Target: $90
Current: $43.93
Upside: +104.87%
Oct 7, 2025
Reiterated: Buy
Price Target: $8
Current: $1.84
Upside: +334.78%
Oct 2, 2025
Reiterated: Buy
Price Target: $18
Current: $2.87
Upside: +527.18%
Jun 16, 2025
Reiterated: Buy
Price Target: $65
Current: $0.5668
Upside: n/a
Jun 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.68
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $15.73
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $151.37
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: $14
Current: $11.94
Upside: n/a
Nov 8, 2024
Reiterated: Hold
Price Target: $17
Current: $25.43
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $95
Current: $55.76
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Nov 4, 2024
Reiterated: Buy
Price Target: $9
Current: $0.95
Upside: n/a
Oct 17, 2024
Reiterated: Buy
Price Target: $9 → $10
Current: $20.44
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.63
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $9.83
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $3.78
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $11.04
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $0.922
Upside: n/a
Aug 22, 2019
Reiterated: Buy
Price Target: $10 → $9
Current: $2.17
Upside: n/a
Aug 14, 2019
Reiterated: Buy
Price Target: $15 → $7
Current: $13.65
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.77
Upside: n/a
Mar 24, 2019
Reiterated: Buy
Price Target: n/a
Current: $1.26
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.3684
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $3.54
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $13.30
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $10.24
Upside: n/a
Mar 30, 2016
Reiterated: Sell
Price Target: $2 → $0.25
Current: $3.34
Upside: n/a